In a 13D filing on Amylin Pharmaceuticals (Nasdaq: AMLN), activist investor Carl Icahn disclosed he raised his stake in the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE